DUBLIN, IRELAND--(Marketwired - December 17, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference. Timothy P. Walbert, chairman, president and chief executive officer, will present at 11:30 a.m. Pacific Time (1:30 p.m. Central Time) on January 13, 2016. Mr. Walbert will review the company’s financials, provide details regarding its orphan, primary care and rheumatology business units and business development strategy.
The presentation will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizon-pharma.com. A replay of each webcast will be available following the events.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and rheumatology business units. Horizon’s global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
Investors:
John Thomas
Executive Vice President
Strategy and Investor Relations
Investor-relations@horizonpharma.com
Tina Ventura
Vice President
Investor Relations
investor-relations@horizonpharma.com
U.S. Media:
Geoff Curtis
Group Vice President
Corporate Communications
gcurtis@horizonpharma.com
Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie
